Global Pharmaceutical Analytical Testing Outsourcing Market

Pharmaceutical Analytical Testing Outsourcing Market Size, Share, Growth Analysis, By Services (Bioanalytical Testing, Method Development & Validation), By End Use (Pharmaceutical Companies, Biopharmaceutical Companies), By Region - Industry Forecast 2025-2032


Report ID: SQMIG35C2024 | Region: Global | Published Date: October, 2024
Pages: 219 | Tables: 97 | Figures: 76

Pharmaceutical Analytical Testing Outsourcing Market Competitive Landscape

The global pharmaceutical analytical testing outsourcing industry has a competitive environment that consists of both well-known international corporations and some emerging niche players. Eurofins Scientific, Labcorp Drug Development, Charles River Laboratories and WuXi AppTec are among the companies that provide an array of testing services together with regulatory compliance and the latest technologies. These players endeavor to strengthen their service portfolios and increase their footprint globally in response to the rise in demand for efficient analytical testing services in the pharmaceutical vertical. 

Top Player’s Company Profiles 

  • Eurofins Scientific SE 
  • Laboratory Corporation of America Holdings 
  • Charles River Laboratories International, Inc. 
  • WuXi AppTec 
  • SGS SA 
  • PPD, Inc. 
  • Intertek Group plc 
  • Almac Group 
  • Pace Analytical Services, LLC 
  • Source BioScience plc 
  • Syneos Health 
  • BioReliance Corporation 
  • LGC Limited 
  • Pharmaceutical Product Development, LLC 
  • Toxikon Corporation 
  • Avista Pharma Solutions 
  • Harlan Laboratories Ltd 
  • Accutest Laboratories 
  • Neopharm Labs Inc. 

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Pharmaceutical Analytical Testing Outsourcing Market size was valued at USD 7.62 billion in 2022 and is poised to grow from USD 8.32 billion in 2023 to USD 15.89 billion by 2031, growing at a CAGR of 8.42% during the forecast period (2024-2031). 

The global pharmaceutical analytical testing outsourcing industry has a competitive environment that consists of both well-known international corporations and some emerging niche players. Eurofins Scientific, Labcorp Drug Development, Charles River Laboratories and WuXi AppTec are among the companies that provide an array of testing services together with regulatory compliance and the latest technologies. These players endeavor to strengthen their service portfolios and increase their footprint globally in response to the rise in demand for efficient analytical testing services in the pharmaceutical vertical.  'Eurofins Scientific SE ', 'Laboratory Corporation of America Holdings ', 'Charles River Laboratories International, Inc. ', 'WuXi AppTec ', 'SGS SA ', 'PPD, Inc. ', 'Intertek Group plc ', 'Almac Group ', 'Pace Analytical Services, LLC ', 'Source BioScience plc ', 'Syneos Health ', 'BioReliance Corporation ', 'LGC Limited ', 'Pharmaceutical Product Development, LLC ', 'Toxikon Corporation ', 'Avista Pharma Solutions ', 'Harlan Laboratories Ltd ', 'Accutest Laboratories ', 'Neopharm Labs Inc. '

With the global regulatory demands becoming more and more serious, ensuring compliance with drug safety and effectiveness becomes important for pharmaceutical manufacturers. The increasing demand for outsourced analytical testing services is primarily driven by the need among firms to obtain specialized skills, minimize the chances of failing to adhere to regulatory requirements, and ensure the quality of the firm's products. 

Rising Demand for Biologic Drug Testing: The increasing focus on biologics and biosimilars is driving demand for specialized pharmaceutical analytical testing outsourcing services. Outsourcing bioanalytical tests is a great benefit for the pharmaceutical companies, as it allows them to take advantage of modern technologies as well as skills, in the development of the biologics, which in turn, safeguards the quality and regulatory requirements of the best complicated drugs. 

Europe dominates the global pharmaceutical analytical testing outsourcing market due to its strong regulatory frameworks, well-established pharmaceutical industry, and extensive infrastructure for drug development and testing. The region has mastered the presence of many pharmaceutical companies and research institutions, which have built a high level of innovation. Ethospa's regional market is further enhanced by Europe's high standards of drug safety and efficacy and the growing appetite for top quality testing services. In addition, lower cost of service delivery through outsourcing, sophisticated bioanalytical methods as well as the concentration of clinical trials in the region make Europe to command the market thus making it the major player in the global pharmaceutical analytical testing outsourcing market. 

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Pharmaceutical Analytical Testing Outsourcing Market

Report ID: SQMIG35C2024

$5,300
BUY NOW GET FREE SAMPLE